MedMira's Biosensor Division to Collaborate with National Research Council on Breast Cancer Research
The NRC/Maple Biosciences partnership shall bring together research and the mapleTWO technology resulting in advanced diagnostics and additional accuracy in the classification of the various breast cancer development stages. mapleTWO, based on the SKN (scanning Kelvin nanoprobe) technology, is a sensitive tool for detecting the biomolecular interactions that form the heart of clinical diagnostics.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.